Importantly, TNBC exhibit a distinctive PRMT5 subcellular distribution, with significantly lower levels of nuclear PRMT5 than healthy breast tissues and all other breast cancer subtypes (Figure 1C). This evidence concerns the gene PRMT5 and breast carcinoma.